Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £187.5m
Position in Universe th / 6846

China's Beijing offers home-made coronavirus vaccines to foreigners

Fri 26th March, 2021 6:57am
BEIJING, March 26 (Reuters) - China's capital of Beijing has
started offering domestically developed COVID-19 vaccines to
foreigners, the city's foreign affairs office said on Friday.
    Foreigners without the city-backed insurance scheme will pay
93.5 yuan ($14.29) per dose for the two shot-based regimen,
while vaccination would be free for those covered by the
insurance.
    In its notice on social media, the city did not identify the
vaccines to be given to non-Chinese, but said they would make
use of "inactivated" coronavirus, killed to ensure it cannot
infect people but can trigger immune response.
    Three of the four Chinese vaccines approved for general
public use are in the inactivated category. Two are from units
of China National Pharmaceutical Group (Sinopharm) and one from
Sinovac Biotech  SVA.O .
    Millions of doses made by Sinopharm and Sinovac have been
supplied overseas via exports or donations. 
    On Tuesday, the commercial hub of Shanghai said it would
allow non-Chinese to make vaccination reservations from next
week.  urn:newsml:reuters.com:*:nL4N2LM02B
($1=6.5409 Chinese yuan renminbi)

 (Reporting by Roxanne Liu and Ryan Woo; Editing by Michael
Perry)
 ((hongkong.newsroom@thomsonreuters.com; (8610)6627-1277;
Reuters Messaging: roxanne.liu@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.